Symbol="PEPG"
AssetType="Common Stock"
Name="PepGen Ltd"
Description="PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious neurological and neuromuscular diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1835597"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="202150000"
EBITDA="-71825000"
PERatio="None"
PEGRatio="None"
BookValue="6.93"
DividendPerShare="0"
DividendYield="0"
EPS="-2.39"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.272"
ReturnOnEquityTTM="-0.479"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.39"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="24.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.665"
EVToRevenue="-"
EVToEBITDA="-2.165"
Beta="None"
num_52WeekHigh="20"
num_52WeekLow="4.32"
num_50DayMovingAverage="12.91"
num_200DayMovingAverage="13.47"
SharesOutstanding="23782300"
DividendDate="None"
ExDividendDate="None"
symbol="PEPG"
open="8.44"
high="8.77"
low="8.22"
price="8.35"
volume="26372.00"
latest_trading_day="2023-07-13"
previous_close="8.49"
change="-0.14"
change_percent="-1.6490%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="79"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="51090"
Change_recent_avg="-0.16"
Delta_recent_avg="1.34"
Variance_recent_avg="0.67"
Change_ratio_recent_avg="-1.5"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="1151"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0184.jpeg"
image_negative_thumbnail_id_2="519"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_neutral_thumbnail_id_1="594"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="635"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0073.jpeg"
image_positive_thumbnail_id_2="661"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0047.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
